{"id":447609,"title":"What was heard: Consultation on interim order transition for COVID-19 drugs - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T14:53:29.068000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/authorization/what-was-heard-consultation-interim-order-transition.html?wbdisable=false","snippet":"What was heard: Consultation on interim order transition for COVID-19 drugs See the regulations notice about the new Clinical Trials for Medical Devices and Drugs Relating to COVID-19 Regulations . These new Regulations, published in the Canada Gazette II on March 2, 2022, came…","rawSnapshotUrl":"/api/snapshots/raw/447609","browseUrl":"https://replay.healtharchive.ca/job-6/20260103145329/https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/authorization/what-was-heard-consultation-interim-order-transition.html?wbdisable=false#ha_snapshot=447609","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}